A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure

Canadian Journal of Cardiology

Volumn 16, Issue 9, 2000, Pages 1155-1166

  Lacourciere, Y ^a   Poirier, L ^a   Lefebvre, J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Blood pressure; Hypertension

Indexed keywords

AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CILAZAPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; IRBESARTAN; ISRADIPINE; LISINOPRIL; LOSARTAN; METOPROLOL; MIBEFRADIL; NEBIVOLOL; NIFEDIPINE; QUINAPRIL; TIAPAMIL; TRANDOLAPRIL; UNINDEXED DRUG; VALSARTAN; ZOFENOPRIL;

AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; HUMAN; HYPERTENSION; MORTALITY; REVIEW; SUSTAINED RELEASE PREPARATION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; COMPARATIVE STUDY; HUMAN; HYPERTENSION; RECEPTORS, ANGIOTENSIN; SUPPORT, NON-U.S. GOV'T;

EID: 0033792702     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Canadian Hypertension society guidelines for ambulatory blood pressure monitoring
2. Incidence of overestimation and underestimation of hypertension in a large sample of Canadians with mild to moderate hypertension
3. Ambulatory blood pressure - An independent predictor of prognosis in essential hypertension
4. Circadian variation and triggers of acute cardiovascular disease
5. Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy
6. The role of ambulatory blood pressure monitoring in evaluating hypertensive patients and their treatment
7. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring
8. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine
9. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol
10. Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group
11. A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring
12. Duration of the antihypertensive action of atenolol, enalapril and placebo: A randomized within-patient study using ambulatory blood pressure monitoring
13. Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements
14. Assessment of antihypertensive effect by blood pressure monitoring: Applications to bisoprolol and lisinopril in a double-blind study
15. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring
16. Labetalol blunts morning pressor surge in systolic hypertension
17. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial design trial
18. A double-blind cross-over comparison of nebivolol and lisinopril in the treatment of ambulatory hypertension
19. Comparative effects of a new cardioselective beta-blocker nebivolol and nifedipine sustained-release on 24-hour ambulatory blood pressure and plasma lipoproteins
20. Fixed low-dose combination therapy in hypertension - A dose response study of perindopril and indapamide
21. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group
22. Antihypertensive effects of combined lisinopril and hydrochlorothiazide in elderly patients with systolodiastolic or systolic hypertension: Results of a multicenter trial
23. The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring Irbesartan Multicenter Study Group
24. Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressure in mild to moderate hypertension
25. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension
26. Low dose hydrochlorothiazide (12.5 to 25 mg daily) as monotherapy in black patients with mild to moderate hypertension. Assessment by ambulatory blood pressure monitoring
27. Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: A double-blind crossover study in known responders to a standard combination
28. Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captopril
29. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: Results of two randomized double-blind controlled studies
30. ACE-inhibitors as first-line treatment agents: A comparative study of trandolapril and enalapril on casual and ambulatory blood pressures
31. Effects of amlodipine and/or fosinopril on renal function in ambulatory hypertensive patients with non-insulin-dependant diabetes mellitus and preserved renal function
32. Antihypertensive effects of cilazapril, 2.5 and 5 mg, once daily versus placebo on ambulatory blood pressure following single and repeat-dose administration
33. Discrerpancies between clinic and ambulatory blood pressure responses to cilazapril therapy
34. The antihypertensive efficacy of the novel calcium antagonist mibefradil comparison with nifedipine GITS in moderate to severe hypertensives with ambulatory hypertension
35. Comparative efficacy of perindopril and enalapril once daily using 24-hour ambulatory blood pressure monitoring
36. A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension
37. Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures
38. Effect of timing of administration on the plasma Ace inhibitory activity and the antihypertensive effect of quinapril
39. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/ Hydrochlorothiazide Investigators
40. A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM
41. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group
42. Comparison of the effects of amlodipine and captopril on clinic and ambulatory blood pressure
43. Comparison of enalapril to captopril by 24-hour ambulatory blood pressure monitoring
44. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists
45. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass
46. Once-daily antihypertensive treatment with calcium antagonists: Utopia or reality?
47. Antihypertensive effect of tiapamil, a calcium antagonist. Double-blind placebo crossover study
48. Efficacy and tolerability of tiapamil in patients with mild to moderate essential hypertension
49. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure
50. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: A forced titration study
51. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension
52. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo-controlled study
53. Comparative effects of diltiazem sustained release formulation and metoprolol on ambulatory pressure and lipoproteins
54. Efficacy of antihypertensive drugs given once a day: The calcium antagonists revisited
55. The angiotensin II receptor antagonist losartan: A new advance in the treatment of hypertension
56. Effects of modulators of the renin-angiotensin-aldosterone system on cough
57. Blood pressure effects of the angiotensin II receptor blocker, losartan
58. Valsartan, a new angiotensin II antagonist: Antihypertensive effects over 24 hours
59. Twenty four-hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension
60. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine
61. 24 hour blood pressure control by once daily administration of irbesartan assessed by ambulatory blood pressure monitoring
62. Comparison of office and ambulatory measurements to assess to angiotensin II receptor antagonist eprosartan
63. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring
64. Comparative effects of losartan and enalapril on urinary albumin excretion and glomerular filtration rate in hypertensive patients with noninsulin dependent diabetes mellitus and microalbuminuria
65. Comparative efficacy of losartan and valsartan in mild-to-moderate hypertension: Results of 24-hour ambulatory blood pressure monitoring
66. Comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure, after a missed dose in truly hypertensive patients: A placebo-controlled forced titration study
67. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild- to-moderate hypertension
68. ABPM comparison of telmisartan and valsartan in patients with mild-to-moderate hypertension